Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation
Objective: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective medications to reduce appetite and body weight. These actions are centrally mediated; however, the neuronal substrates involved are poorly understood. Methods: We employed a combination of neuroanatomical, genetic, and beh...
Saved in:
Main Authors: | Alessia Costa (Author), Minrong Ai (Author), Nicolas Nunn (Author), Isabella Culotta (Author), Jenna Hunter (Author), Mehdi Boutagouga Boudjadja (Author), Lourdes Valencia-Torres (Author), Gabriella Aviello (Author), David J. Hodson (Author), Brandy M. Snider (Author), Tamer Coskun (Author), Paul J. Emmerson (Author), Simon M. Luckman (Author), Giuseppe D'Agostino (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GIP receptor agonism blocks chemotherapy-induced nausea and vomiting
by: Tito Borner, et al.
Published: (2023) -
Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatide
by: Karen Schneck, et al.
Published: (2024) -
Loss of GIPR in LEPR cells impairs glucose control by GIP and GIP:GLP-1 co-agonism without affecting body weight and food intake in mice
by: Seun Akindehin, et al.
Published: (2024) -
Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism
by: Piotr A. Mroz, et al.
Published: (2019) -
Spatiotemporal GLP-1 and GIP receptor signaling and trafficking/recycling dynamics induced by selected receptor mono- and dual-agonists
by: Aaron Novikoff, et al.
Published: (2021)